John G. Ullman & Associates’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $317K | Sell |
2,680
-100
| -4% | -$11.5K | 0.04% | 158 |
|
|
2026
Q1 | $332K | Sell |
2,780
-50
| -2% | -$6.56K | 0.04% | 147 |
|
|
2025
Q4 | $385K | Hold |
2,830
| – | – | 0.05% | 143 |
|
|
2025
Q3 | $417K | Buy |
2,830
+250
| +10% | +$34.7K | 0.06% | 134 |
|
|
2025
Q2 | $334K | Hold |
2,580
| – | – | 0.05% | 143 |
|
|
2025
Q1 | $308K | Hold |
2,580
| – | – | 0.05% | 148 |
|
|
2024
Q4 | $299K | Hold |
2,580
| – | – | 0.04% | 150 |
|
|
2024
Q3 | $348K | Buy |
2,580
+220
| +9% | +$29.4K | 0.05% | 149 |
|
|
2024
Q2 | $320K | Hold |
2,360
| – | – | 0.05% | 153 |
|
|
2024
Q1 | $305K | Buy |
2,360
+300
| +15% | +$36.2K | 0.05% | 146 |
|
|
2023
Q4 | $236K | Buy |
+2,060
| New | +$206K | 0.04% | 151 |
|
|
2023
Q3 | – | Sell |
-2,060
| Closed | -$232K | – | 182 |
|
|
2023
Q2 | $232K | Buy |
+2,060
| New | +$218K | 0.04% | 163 |
|
|
2017
Q4 | – | Sell |
-37,850
| Closed | -$2.37M | – | 116 |
|
|
2017
Q3 | $2.37M | Sell |
37,850
-1,050
| -3% | -$62.8K | 0.46% | 62 |
|
|
2017
Q2 | $2.16M | Sell |
38,900
-950
| -2% | -$49.5K | 0.43% | 69 |
|
|
2017
Q1 | $2M | Sell |
39,850
-800
| -2% | -$39K | 0.41% | 67 |
|
|
2016
Q4 | $2.01M | Sell |
40,650
-1,850
| -4% | -$93.8K | 0.42% | 70 |
|
|
2016
Q3 | $2.23M | Sell |
42,500
-800
| -2% | -$39.2K | 0.46% | 64 |
|
|
2016
Q2 | $1.93M | Sell |
43,300
-200
| -0.5% | -$8.69K | 0.4% | 67 |
|
|
2016
Q1 | $1.78M | Sell |
43,500
-1,350
| -3% | -$49.7K | 0.42% | 64 |
|
|
2015
Q4 | $1.64M | Sell |
44,850
-1,150
| -3% | -$41.6K | 0.36% | 70 |
|
|
2015
Q3 | $1.51M | Sell |
46,000
-4,800
| -9% | -$161K | 0.36% | 72 |
|
|
2015
Q2 | $1.88M | Sell |
50,800
-6,190
| -11% | -$225K | 0.35% | 85 |
|
|
2015
Q1 | $2M | Sell |
56,990
-3,225
| -5% | -$114K | 0.38% | 74 |
|
|
2014
Q4 | $2.29M | Sell |
60,215
-3,250
| -5% | -$119K | 0.43% | 66 |
|
|
2014
Q3 | $2.25M | Sell |
63,465
-1,505
| -2% | -$55.9K | 0.43% | 66 |
|
|
2014
Q2 | $2.54M | Sell |
64,970
-1,680
| -3% | -$62.8K | 0.46% | 60 |
|
|
2014
Q1 | $2.43M | Sell |
66,650
-900
| -1% | -$32.8K | 0.45% | 62 |
|
|
2013
Q4 | $2.34M | Sell |
67,550
-1,900
| -3% | -$61.1K | 0.45% | 59 |
|
|
2013
Q3 | $1.94M | Buy |
69,450
+28,300
| +69% | +$754K | 0.4% | 67 |
|
|
2013
Q2 | $1.11M | Buy |
+41,150
| New | +$1.14M | 0.23% | 92 |
|
Other funds holding XYL
John G. Ullman & Associates's XYL Position: Q2 2026 in Review
John G. Ullman & Associates reduced its Xylem (XYL) stake by 3.6% in Q2 2026, selling an estimated $11.5K and leaving 2,680 shares worth $317K. The position accounts for 0.04% of the portfolio, ranked #158.
John G. Ullman & Associates first reported a position in XYL in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.54M in Q2 2014. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- John G. Ullman & Associates held 2,680 shares of Xylem worth $317K as of Q2 2026.
- John G. Ullman & Associates sold 100 Xylem shares in Q2 2026, an estimated $11.5K.
- Xylem made up 0.04% of John G. Ullman & Associates's portfolio in Q2 2026, its #158 holding.
- John G. Ullman & Associates first reported a position in Xylem in Q2 2013 and has held it in 30 quarters since.
- John G. Ullman & Associates's Xylem position peaked at $2.54M in Q2 2014.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on John G. Ullman & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.